Acrux Limited ACR Articles
Date: 23 Nov 2015
Slowing global and domestic growth is expected to weigh on investment returns in 2016, as both developed and developing economies struggle to pick up speed
Date: 23 Oct 2013
While the positive attributes and competitive advantages of Australian narrow-moat healthcare giants CSL Limited (CSL) and Cochlear Limited (COH) will be well-known to Morningstar readers, it's easy to forget there are other companies within the sector that may add value to certain portfolios
Market Cap:$52 M (as of 09/01/2017 04:40 PM )
Style: Small Value
View Price Quote: for Acrux Limited
Advantages of Premium Membership
Your Money Weekly Newsletter
Independent stocks newsletter has been aiding Australian investors for over 30 years.
Independent Fund Analyst Research
For the first time in Australia Morningstar Qualitative Fund Research is directly available to individual investors.
Ensure your portfolio is positioned exactly how you want with Morningstar's Portfolio X-Ray. You can discover how much of a stock you really own, individually and through managed funds with Stock Intersection.
Find greatly undervalued stocks to consider daily. Browse our Fund Analyst Picks to find managed funds that best suit your needs.
Access these features and more when you sign up for Premium Membership.
Start your complimentary trial now!